Compare FSLY & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FSLY | OPCH |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | N/A | 8266 |
| Industry | Computer Software: Prepackaged Software | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.1B |
| IPO Year | 2019 | 1996 |
| Metric | FSLY | OPCH |
|---|---|---|
| Price | $17.18 | $19.52 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $18.00 | ★ $36.57 |
| AVG Volume (30 Days) | ★ 10.2M | 4.1M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.19 | 3.25 |
| EPS | N/A | ★ 0.29 |
| Revenue | $624,018,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | $16.39 | $7.21 |
| Revenue Next Year | $10.73 | $8.55 |
| P/E Ratio | ★ N/A | $68.71 |
| Revenue Growth | 14.78 | ★ 16.17 |
| 52 Week Low | $6.29 | $18.01 |
| 52 Week High | $34.82 | $36.80 |
| Indicator | FSLY | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 36.69 | 23.93 |
| Support Level | $16.41 | $18.01 |
| Resistance Level | $20.27 | $29.13 |
| Average True Range (ATR) | 2.17 | 0.96 |
| MACD | -1.08 | -0.20 |
| Stochastic Oscillator | 0.28 | 15.05 |
Fastly Inc is a cloud computing company that provides an edge cloud platform designed to deliver, secure, and optimize digital experiences over the internet. The company operates a unified platform that combines content delivery, edge computing, and security capabilities. Its services include content delivery networks, web and API protection, distributed denial of service mitigation, and real-time data processing at the edge. Its platform enables customers to improve the performance, scalability, and security of applications and digital content, and also supports cloud-native architectures, AI-driven workloads, and programmable edge computing solutions.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.